We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock

Delisted

SRRA was delisted on the 30th of June, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
VC
1
Vivo Capital
California
$20.5M
O
2
OrbiMed
New York
$15.8M
A
3
Abingworth
United Kingdom
$9.21M
CC
4
Caxton Corporation
New Jersey
$6.87M
MP
5
Mangrove Partners
Connecticut
$4.42M -$86.7K -7,280 -2%
NLVP
6
New Leaf Venture Partners
New York
$4.37M
IC
7
Ikarian Capital
Texas
$3.35M +$3.62M +304,232 +3,150%
FM
8
Frazier Management
Washington
$2.16M
6CM
9
683 Capital Management
New York
$1.5M
Millennium Management
10
Millennium Management
New York
$1.33M +$1.49M +124,766 New
Renaissance Technologies
11
Renaissance Technologies
New York
$1.08M +$78.6K +6,600 +7%
PA
12
Perceptive Advisors
New York
$711K
BCM
13
Bridgeway Capital Management
Texas
$573K +$224K +18,800 +54%
BFM
14
Boothbay Fund Management
New York
$405K +$453K +38,001 New
Northern Trust
15
Northern Trust
Illinois
$379K +$8.85K +743 +2%
PVI
16
Pura Vida Investments
New York
$202K
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$141K -$917 -77 -0.6%
WG
18
Winton Group
United Kingdom
$111K +$124K +10,421 New
Morgan Stanley
19
Morgan Stanley
New York
$109K +$118K +9,874 +2,626%
S
20
SignatureFD
Georgia
$53K
BlackRock
21
BlackRock
New York
$47K +$5.18K +435 +11%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$23K -$208K -17,456 -89%
TRCT
23
Tower Research Capital (TRC)
New York
$4K -$68.5K -5,753 -94%
Group One Trading
24
Group One Trading
Illinois
$2K
Wells Fargo
25
Wells Fargo
California
$2K